(i) Pathways and signalling molecules

Current Orthopaedics

Volumn 21, Issue 4, 2007, Pages 249-257

  Nikolaou, V S ^a   Tsiridis, E ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Bone; Enhancement; Fracture; Healing; Molecules

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METALLOPROTEINASE; PARATHYROID HORMONE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; EX VIVO GENE TRANSFER; FRACTURE HEALING; FRACTURE TREATMENT; HUMAN; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 34848875731     PISSN: 02680890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cuor.2007.08.001     Document Type: Article

References (73)

1. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg Br 60-B 2 (1978) 150-162
2. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355 Suppl. (1998) S7-S21
3. Dimitriou R., Tsiridis E., and Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 36 12 (2005) 1392-1404
4. Gerstenfeld L.C., et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88 5 (2003) 873-884
5. Kon T., et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16 6 (2001) 1004-1014
6. Einhorn T.A., et al. The expression of cytokine activity by fracture callus. J Bone Miner Res 10 8 (1995) 1272-1281
7. Lehmann W., et al. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36 2 (2005) 300-310
8. ten Dijke P., et al. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am 85-A Suppl. 3 (2003) 34-38
9. Cho T.J., Gerstenfeld L.C., and Einhorn T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17 3 (2002) 513-520
10. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 6 (1998) 591-603
11. Valdimarsdottir G., et al. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106 17 (2002) 2263-2270
12. Bostrom M.P., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13 3 (1995) 357-367
13. Urist M.R. Bone: formation by autoinduction. Science 150 698 (1965) 893-899
14. Cheng H., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A 8 (2003) 1544-1552
15. Deckers M.M., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 4 (2002) 1545-1553
16. Bostrom M.P. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 355 Suppl. (1998) S116-S123
17. Riedel G.E., and Valentin-Opran A. Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. Orthopedics 22 7 (1999) 663-665
18. Govender S., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A 12 (2002) 2123-2134
19. Geesink R.G., Hoefnagels N.H., and Bulstra S.K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81 4 (1999) 710-718
20. Friedlaender G.E., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl. 1 (Pt 2) (2001) S151-S158
21. Kekow J., and Gross W.L. Transforming growth factor beta: its mechanism of action and clinical significance. Dtsch Med Wochenschr 117 6 (1992) 228-235
22. Sumner D.R., et al. Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am 77 8 (1995) 1135-1147
23. Baylink D.J., Finkelman R.D., and Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 8 Suppl. 2 (1993) S565-S572
24. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8 2 (1994) 133-146
25. Cornell C.N., and Lane J.M. Newest factors in fracture healing. Clin Orthop Relat Res 277 (1992) 297-311
26. Lieberman J.R., Daluiski A., and Einhorn T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A 6 (2002) 1032-1044
27. Barnes G.L., et al. Growth factor regulation of fracture repair. J Bone Miner Res 14 11 (1999) 1805-1815
28. Joyce M.E., Jingushi S., and Bolander M.E. Transforming growth factor-beta in the regulation of fracture repair. Orthop Clin North Am 21 1 (1990) 199-209
29. Heldin C.H., and Westermark B. PDGF-like growth factors in autocrine stimulation of growth. J Cell Physiol Suppl Suppl. 5 (1987) 31-34
30. Hart C.E., and Bowen-Pope D.F. Platelet-derived growth factor receptor: current views of the two-subunit model. J Invest Dermatol 94 6 Suppl. (1990) 53S-57S
31. Bolander M.E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200 2 (1992) 165-170
32. Nash T.J., et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15 2 (1994) 203-208
33. Fujii H., et al. Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. Histochem Cell Biol 112 2 (1999) 131-138
34. Radomsky M.L., et al. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop Relat Res 355 Suppl. (1998) S283-S293
35. Wang J.S. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand Suppl 269 (1996) 1-33
36. Bourque W.T., Gross M., and Hall B.K. Expression of four growth factors during fracture repair. Int J Dev Biol 37 4 (1993) 573-579
37. Jingushi S., et al. Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. J Orthop Res 8 3 (1990) 364-371
38. Nakamura T., et al. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13 6 (1998) 942-949
39. Kawaguchi H., et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135 2 (1994) 774-781
40. Nakamura K., et al. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 15 2 (1997) 307-313
41. Ernst M., and Froesch E.R. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Commun 151 1 (1988) 142-147
42. Panagakos F.S. Insulin-like growth factors-I and -II stimulate chemotaxis of osteoblasts isolated from fetal rat calvaria. Biochimie 75 11 (1993) 991-994
43. Prisell P.T., et al. Expression of insulin-like growth factors during bone induction in rat. Calcif Tissue Int 53 3 (1993) 201-205
44. Aspenberg P., Albrektsson T., and Thorngren K.G. Local application of growth-factor IGF-1 to healing bone. Experiments with a titanium chamber in rabbits. Acta Orthop Scand 60 5 (1989) 607-610
45. Kirkeby O.J., and Ekeland A. No effects of local somatomedin C on bone repair. Continuous infusion in rats. Acta Orthop Scand 63 4 (1992) 447-450
46. Thaller S.R., Dart A., and Tesluk H. The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 31 5 (1993) 429-433
47. Thaller S.R., et al. Effect of insulin-like growth factor-1 on zygomatic arch bone regeneration: a preliminary histological and histometric study. Ann Plast Surg 31 5 (1993) 421-428
48. Chhabra A., et al. BMP-14 deficiency inhibits long bone fracture healing: a biochemical, histologic, and radiographic assessment. J Orthop Trauma 19 9 (2005) 629-634
49. Spiro R.C., Thompson A.Y., and Poser J.W. Spinal fusion with recombinant human growth and differentiation factor-5 combined with a mineralized collagen matrix. Anat Rec 263 4 (2001) 388-395
50. Vu T.H., et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 3 (1998) 411-422
51. Takahara M., et al. Matrix metalloproteinase-9 expression, tartrate-resistant acid phosphatase activity, and DNA fragmentation in vascular and cellular invasion into cartilage preceding primary endochondral ossification in long bones. J Orthop Res 22 5 (2004) 1050-1057
52. Gerber H.P., et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5 6 (1999) 623-628
53. Street J., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99 15 (2002) 9656-9661
54. Komarova S.V. Mathematical model of paracrine interactions between osteoclasts and osteoblasts predicts anabolic action of parathyroid hormone on bone. Endocrinology 146 8 (2005) 3589-3595
55. Fukuhara H., and Mizuno K. The influence of parathyroid hormone on the process of fracture healing. Nippon Seikeigeka Gakkai Zasshi 63 1 (1989) 100-115
56. Andreassen T.T., Ejersted C., and Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14 6 (1999) 960-968
57. Alkhiary Y.M., et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87 4 (2005) 731-741
58. Nakajima A., et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17 11 (2002) 2038-2047
59. Neer R.M., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 19 (2001) 1434-1441
60. Koskinen E.V. The repair of experimental fractures under the action of growth hormone, thyrotropin and cortisone. A tissue analytic, roentgenologic and autoradiographic study. Ann Chir Gynaecol Fenn Suppl 48 90 (1959) 1-48
61. Bak B., Jorgensen P.H., and Andreassen T.T. Increased mechanical strength of healing rat tibial fractures treated with biosynthetic human growth hormone. Bone 11 4 (1990) 233-239
62. Carpenter J.E., et al. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. J Bone Joint Surg Am 74 3 (1992) 359-367
63. Raschke M., et al. Homologous growth hormone accelerates healing of segmental bone defects. Bone 29 4 (2001) 368-373
64. Bail H.J., et al. Systemic application of growth hormone for enhancement of secondary and intramembranous fracture healing. Horm Res 58 Suppl. 3 (2002) 39-42
65. Meier C.R., et al. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283 24 (2000) 3205-3210
66. Wang P.S., et al. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283 24 (2000) 3211-3216
67. Skoglund B., Forslund C., and Aspenberg P. Simvastatin improves fracture healing in mice. J Bone Miner Res 17 11 (2002) 2004-2008
68. Chen Y. Orthopedic applications of gene therapy. J Orthop Sci 6 2 (2001) 199-207
69. Lieberman J.R., et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81 7 (1999) 905-917
70. Shen H.C., et al. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med 6 9 (2004) 984-991
71. Deasy B.M., Li Y., and Huard J. Tissue engineering with muscle-derived stem cells. Curr Opin Biotechnol 15 5 (2004) 419-423
72. Peng H., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110 6 (2002) 751-759
73. Peng H., et al. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther 12 2 (2005) 239-246